In a recent interview, Bill Gates noted that due to a number of challenges, a technology transfer of vaccines should not be considered. However, his claims do not fit the reality and needs of the world.
Gates said a technology or “prescription” transfer of vaccines should not be made to other countries.
He called it a big challenge that has never been done before.
He also cited vaccine trials as a reason to avoid this transmission.
Bill Gates has been in the headlines for a variety of reasons since the start of the Covid-19 pandemic.
The tech mogul has been celebrated, ridiculed and even devastatingly criticized for his stance on the production and distribution of a candidate vaccine for the new disease.
A new comment from Gates puts him in a bad light again as the tech entrepreneur suggests not to share proprietary vaccines with other countries. In an interview with Sky News, Bill Gates was asked if a change to the intellectual property law is helpful in the current Covid crisis?
The rationale was to share the vaccine formula and production techniques with countries other than the US to enable local production. To the surprise (and shock) of many, Gates said no. He gave a number of reasons for his argument.
One of these was the limited vaccine factories around the world. Another was the process of transferring the technology itself, which wouldn’t be very effective without the “grants” and “expertise” that the US has, according to Gates.
Both are vague, uninspiring reasons and untrue at the slightest thought. But even if you start to think of them as legitimate challenges, it’s what Gates said in the middle that attacked the deaf ears.
Moving something that had never been done before, moving a vaccine from, say, a J&J factory to a factory in India, that’s new.
‘India? Really? If Gates hadn’t mentioned a specific country in his comment, he might have had a chance to get away with the comment.But since the country has the highest vaccine production capacity in the world, the comment lost its credibility almost immediately.
The fact that India is a center for vaccine production is known to the world. Early this year, United Nations Secretary-General Antonio Guterres hailed the country’s vaccine production capacity as “the best asset the world has today” in the fight against Covid-19.
In any case, the backbone of this production is a technology transfer between SII and AstraZeneca, and not an individual attempt to come up with a magical solution. So how Gates can point this out as a challenge is anyone’s guess.
Gates even noted that the vaccine manufacturers are driving such a technology transfer. Why not or rather “shouldn’t be done” is a question that Gates seems very confused about.
You could argue the claims based on the country’s ongoing crisis with the disease. However, this is partly due to the erratic distribution of the vaccine units to other countries and a tragic inadequacy of the country to combat a second wave, but not the lack of vaccine production capacity. Another boring reason he put forward for this was the tests required on vaccine candidates. But remember, every vaccine candidate is tested in every region of use regardless. So you can only guess what Gates was trying to suggest there. This isn’t the first time Gates has come under the radar for his involvement in vaccine availability around the world. As the pandemic evolved and a new perspective on the post-Covid-19 world entered, many began to point the finger at how Gates benefited from these vaccines. A growing number of people from around the world are now claiming that Gates has deliberately pushed the vaccine toward a profitable business model rather than going for vaccine justice, which is the need of the hour. A report from Australian Fair Trade & Investment Network Ltd (AFTINET) points to Gates’ involvement through its Bill and Melinda Gates Foundation in the University of Oxford’s partnership with AstraZeneca to supply its Covid-19 vaccine candidate to countries on the whole world. . The report states that this was a major reason for the vaccine’s exclusive license-controlled distribution rather than an open distribution model for any manufacturer. Since much of this is speculation, Gates cannot be blamed for this. But some hints point to its legitimacy. Gates benefited during the pandemic through sources directly related to the Covid-19-related stocks. Such comments about keeping the vaccines exclusive don’t help his case either.